Literature DB >> 12240530

Multicentric canine lymphoma in a 12-year-old keeshond: chemotherapy options.

Mireille M C Martineau1.   

Abstract

A 12-year-old, spayed female keeshond presenting with lethargy, anorexia, weight loss, and vomiting was diagnosed with multicentric lymphoma. Lymphoma usually responds well to multiagent chemotherapy. Efficacy, cost, toxicity, and duration of treatment determine a treatment protocol. Outcomes are compared on the basis of remission, survival time, and treatment-related toxicity.

Entities:  

Mesh：

Year:  2002        PMID： 12240530      PMCID： PMC339556     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  9 in total

1.  Evaluation of the results of a L-asparaginase-based continuous chemotherapy protocol versus a short doxorubicin-based induction chemotherapy protocol in dogs with malignant lymphoma.

Authors:  C J Piek; G R Rutteman; E Teske
Journal:  Vet Q       Date:  1999-04       Impact factor: 3.320

2.  Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).

Authors:  K D Valerius; G K Ogilvie; C H Mallinckrodt; D M Getzy
Journal:  J Am Vet Med Assoc       Date:  1997-02-15       Impact factor: 1.936

Review 3.  Chemoimmunotherapy of canine lymphoma with adjuvant canine monoclonal antibody 231.

Authors:  K A Jeglum
Journal:  Vet Clin North Am Small Anim Pract       Date:  1996-01       Impact factor: 2.093

4.  Correlation between thoracic radiographic changes and remission/survival duration in 270 dogs with lymphosarcoma.

Authors:  G S Starrak; C R Berry; R L Page; J L Johnson; D E Thrall
Journal:  Vet Radiol Ultrasound       Date:  1997 Nov-Dec       Impact factor: 1.363

5.  Evaluation of a high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma.

Authors:  R Chun; L D Garrett; D M Vail
Journal:  J Vet Intern Med       Date:  2000 Mar-Apr       Impact factor: 3.333

Review 6.  Lymphoma in dogs: chemotherapy.

Authors:  R C Rosenthal
Journal:  Vet Clin North Am Small Anim Pract       Date:  1996-01       Impact factor: 2.093

7.  Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma.

Authors:  C Khanna; E M Lund; K A Redic; D W Hayden; F W Bell; E L Goulland; J S Klausner
Journal:  J Am Vet Med Assoc       Date:  1998-10-01       Impact factor: 1.936

8.  A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.

Authors:  B I Zemann; A S Moore; W M Rand; G Mason; D M Ruslander; A E Frimberger; C A Wood; D A L'Heureux; J Gliatto; S M Cotter
Journal:  J Vet Intern Med       Date:  1998 Nov-Dec       Impact factor: 3.333

9.  Prognostic factors for treatment of malignant lymphoma in dogs.

Authors:  E Teske; P van Heerde; G R Rutteman; I D Kurzman; P F Moore; E G MacEwen
Journal:  J Am Vet Med Assoc       Date:  1994-12-15       Impact factor: 1.936
  9 in total
  2 in total

1.  Alimentary lymphosarcoma in a 4-year-old Labrador retriever.

Authors:  Andrew D Lowe
Journal:  Can Vet J       Date:  2004-07       Impact factor: 1.008

2.  Demonstrating the presence of Ehrlichia canis DNA from different tissues of dogs with suspected subclinical ehrlichiosis.

Authors:  Carlos A Rodríguez-Alarcón; Diana M Beristain-Ruiz; Angélica Olivares-Muñoz; Andrés Quezada-Casasola; Federico Pérez-Casio; Jesús A Álvarez-Martínez; Jane Tapia-Alanís; José J Lira-Amaya; Ramón Rivera-Barreno; Orlando S Cera-Hurtado; José A Ibancovichi-Camarillo; Luis Soon-Gómez; Jaime R Adame-Gallegos; Julio V Figueroa-Millán
Journal:  Parasit Vectors       Date:  2020-10-15       Impact factor: 3.876
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.